DongBang Medical
Financials
Valuation Metrics
DongBang Medical's Market Cap is ₩1225B. At end of 2025 it was ₩1635B. Ranked #1157 of 2,421 in KR market (top 48%), #615 of 1,640 on KOSDAQ (top 38%), #42 of 96 in Health Care Equipment & Services (top 44%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 122.46B KRW | KR#1,157/2,421 Sec#42/96 |
| Revenue | 125.12B KRW | KR#1,286/2,421 Sec#23/96 |
| Net Income | 15.61B KRW | KR#802/2,421 Sec#21/96 |
| Total Assets | 186.53B KRW | KR#1,362/2,421 Sec#38/96 |
| Net Assets | 125.32B KRW | KR#1,265/2,421 Sec#38/96 |
| Employees | 284 | KR#832/2,421 Sec#24/96 |
| Value | ||
| P/E | 7.84x | KR#650/2,421 Sec#18/96 |
| P/B | 0.98x | KR#1,438/2,421 Sec#38/96 |
| PEG | 0.03x | KR#223/2,421 Sec#11/96 |
| P/S | 0.98x | KR#1,376/2,421 Sec#25/96 |
| EV/EBITDA | 5.60x | KR#281/2,421 Sec#9/96 |
| Profitability | ||
| ROE | 12.46% | KR#445/2,421 Sec#19/96 |
| ROA | 8.37% | KR#404/2,421 Sec#23/96 |
| Op. Margin | 17.59% | KR#214/2,421 Sec#19/96 |
| Revenue Growth | 8.01% | KR#1,019/2,421 Sec#58/96 |
| Earnings Growth | 292.63% | KR#170/2,421 Sec#9/96 |
| Financial Health | ||
| Debt Ratio | 48.85% | KR#946/2,421 Sec#52/96 |
| Total Debt | 31.42B KRW | KR#1,206/2,421 Sec#29/96 |
| Cash | 30.64B KRW | KR#999/2,421 Sec#26/96 |
| Current Ratio | 2.04x | KR#852/2,421 Sec#49/96 |
| Net Debt/EBITDA | 0.04x | KR#611/2,421 Sec#24/96 |
| Performance | ||
| 1Y Return | -47.67% | KR#2,000/2,421 Sec#67/96 |
| 1M Return | -5.80% | KR#1,859/2,421 Sec#60/96 |
| From 52W High | -48.86% | KR#1,335/2,421 Sec#41/96 |
| 1Y MDD | -57.51% | KR#1,337/2,421 Sec#43/96 |
| Trading | ||
| Volume | 93,060 shares | KR#815/2,421 Sec#28/96 |
| Trading Value | 539.5M KRW | KR#905/2,421 Sec#25/96 |
| Foreign Own. | 1.08% | KR#2,006/2,421 Sec#77/96 |
| Per Share | ||
| EPS | 746 KRW | KR#842/2,421 Sec#20/96 |
| BPS | 5,986 KRW | KR#1,360/2,421 Sec#33/96 |
Company Info
Dongbang Medical, established in 1985 and converted into a corporation in 2014, listed on the KOSDAQ market in 2025. The company primarily focuses on manufacturing and selling traditional Korean medicine medical devices and aesthetic medical devices, achieving the top domestic market share in disposable traditional Korean medicine acupuncture needles and disposable cupping cups. Leveraging its automated production system and excellent technology, it exports products globally and continuously conducts R&D for product improvement and new market entry. It is headquartered in Boryeong-si, Chungcheongnam-do.